These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 22039822
1. Integrated analysis on the physicochemical properties of dihydropyridine calcium channel blockers in grapefruit juice interactions. Uesawa Y, Takeuchi T, Mohri K. Curr Pharm Biotechnol; 2012 Jul; 13(9):1705-17. PubMed ID: 22039822 [Abstract] [Full Text] [Related]
2. Relationship between lipophilicities of 1,4-dihydropyridine derivatives and pharmacokinetic interaction strengths with grapefruit juice. Uesawa Y, Mohri K. Yakugaku Zasshi; 2008 Jan; 128(1):117-22. PubMed ID: 18176062 [Abstract] [Full Text] [Related]
10. Effects of ingestion of grapefruit juice or grapefruit on the hypotensive effect and plasma concentrations of dihydropyridine calcium antagonists (amlodipine and nifedipine): a case study. Nakagawa K, Goto T. Clin Exp Hypertens; 2010 Jan; 32(2):71-5. PubMed ID: 20374180 [Abstract] [Full Text] [Related]
13. Utilizing in vitro and PBPK tools to link ADME characteristics to plasma profiles: case example nifedipine immediate release formulation. Wagner C, Thelen K, Willmann S, Selen A, Dressman JB. J Pharm Sci; 2013 Sep; 102(9):3205-19. PubMed ID: 23696038 [Abstract] [Full Text] [Related]
14. Effect of grapefruit juice in relation to human pharmacokinetic study. Uno T, Yasui-Furukori N. Curr Clin Pharmacol; 2006 May; 1(2):157-61. PubMed ID: 18666368 [Abstract] [Full Text] [Related]
15. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice. Veronese ML, Gillen LP, Burke JP, Dorval EP, Hauck WW, Pequignot E, Waldman SA, Greenberg HE. J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340 [Abstract] [Full Text] [Related]